Tracy Kehoe, 57, of Manchester, England, initially attributed her increasing forgetfulness to the early stages of dementia, a fear compounded by a family history of the condition. What followed was a diagnosis that dramatically altered her understanding of her symptoms: stage 4 glioblastoma, an aggressive and speedy-growing form of brain cancer. Her story, one of misdiagnosis, resilience, and hopeful progress, highlights the challenges in identifying brain tumors and the importance of persistent medical investigation.
Kehoe first noticed changes in early 2025, experiencing difficulty remembering completed tasks and repeating conversations. “My sister noticed I had been repeating myself and forgetting conversations, which is not like me at all,” she explained, according to SWNS. A colleague at function also observed similar lapses in her memory, noting she struggled to recall whether she’d completed assignments or finalized financial calculations. These subtle but concerning signs prompted Kehoe to seek medical attention, initially suspecting a familial predisposition to dementia, given her father and grandfather had both experienced the condition.
From Dementia Concerns to a Shocking Diagnosis
After visiting Fairfield General Hospital, Kehoe underwent an MRI scan that revealed a tumor in her brain. Subsequent tests confirmed the devastating diagnosis of glioblastoma, a particularly aggressive cancer that forms from glial cells in the brain. According to the National Brain Tumor Society, glioblastoma is the most common malignant brain tumor in adults, with a median survival rate of 12-18 months. Learn more about glioblastoma from the National Brain Tumor Society. Kehoe was initially given a prognosis of six to 18 months to live.
“It’s the most devastating thing that’s ever happened in our entire world,” Kehoe said. “It absolutely floored us since I’m well. I’ve always been well. I have never really been ill.” The unexpected diagnosis brought a wave of uncertainty, disrupting plans for retirement and long-awaited travel with her husband.
An Awake Craniotomy and Promising Results
Despite the grim prognosis, Kehoe underwent an awake craniotomy in August 2025. This complex surgical procedure, performed while the patient is conscious, allows surgeons to remove as much of the tumor as possible while minimizing damage to critical brain functions. According to Johns Hopkins Medicine, awake craniotomies are often used for tumors located near areas of the brain that control speech, movement, and vision. Read more about awake craniotomies from Johns Hopkins Medicine. Surgeons successfully removed 95% of the tumor during the procedure.
Following the surgery, Kehoe completed six weeks of radiotherapy and four cycles of chemotherapy, with two cycles remaining as of March 2026. Remarkably, a recent post-surgery MRI revealed that the tumor is now only visible microscopically, offering a hopeful sign of treatment effectiveness. Doctors are cautiously optimistic about her progress.
A Daughter’s Dedication and a Community’s Support
Kehoe’s daughter, Ellie Hutson, 28, has been a steadfast source of support throughout her mother’s ordeal. Initially shocked by the diagnosis, Hutson channeled her energy into raising awareness and funds for brain tumor research. She organized a charity walk on Sunday, March 22, 2026, bringing together approximately 25 family members and friends to support The Brain Tumor Charity.
Ellie Hutson (left) and mom Tracy Kehoe
Credit: SWNS
“My mom, she’s honestly taking this in her absolute stride,” Hutson said. Participants wore red, the color associated with The Brain Tumor Charity, as they walked in support of Kehoe and others affected by brain tumors. The funds raised will contribute to vital research and support services for patients and families.
Tracy Kehoe’s walking group
Credit: SWNS
Kehoe’s case underscores the importance of considering brain tumors when evaluating symptoms initially attributed to dementia or other neurological conditions. While early diagnosis can be challenging, advancements in surgical techniques and treatment options, like the awake craniotomy and targeted therapies, are offering new hope for patients facing this devastating disease. Kehoe will continue to undergo monitoring and chemotherapy, with her next MRI scheduled for late 2026 to assess the continued response to treatment.
Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute medical advice. It’s essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
What are your thoughts on Tracy’s story? Share your comments below, and please consider sharing this article to raise awareness about brain tumors and the importance of early diagnosis.
